MetLife Investment Advisors LLC Acquires Shares of 31314 Nu Skin Enterprises (NUS)

Marco Green
April 21, 2018

It has underperformed by 11.55% the S&P500.The move comes after 5 months negative chart setup for the $1.88B company. We have $27.88 PT which if reached, will make NASDAQ:ALTR worth $112.50M less. Pivotal Research reiterated a "buy" rating and set a $90.00 price target on shares of Nu Skin Enterprises in a report on Friday, February 16th. Rhumbline Advisers sold 5,262 shares as Nu Skin Enterprises Inc Cl A C (NUS)'s stock rose 3.34%. The Rhumbline Advisers holds 98,228 shares with $6.70 million value, down from 103,490 last quarter. Nu Skin Enterprises Inc Cl A C now has $3.91 billion valuation. The stock increased 1.18% or $0.84 during the last trading session, reaching $72.04. The company had a trading volume of 22,393 shares. Nu Skin Enterprises has an average rating of Hold and a consensus target price of $71.29. (NUS) has risen 33.34% since April 20, 2017 and is uptrending. NUS outperformed by 21.79% the S&P 500.

During 2017 Q4 the big money sentiment increased to 1.16. The company reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.01. It is positive, as 19 investors sold Nu Skin Enterprises, Inc. shares while 75 reduced holdings. Also, the number of hedge funds holding Nu Skin Enterprises Inc in top ten positions was flat from 3 to 3 for the same number. (NYSE:NUS) or 12,300 shs. Wolverine Asset Management LLC increased its holdings in shares of Nu Skin Enterprises by 106.9% during the 4th quarter.

Several large investors have recently bought and sold shares of NUS. Earnest Partners Limited invested in 0% or 25 shares. Funds hold 37.52 million shares thus 2.40% less from 2017Q3's 38.44 million shares. Dimensional Fund Advisors LP boosted its holdings in shares of Nu Skin Enterprises by 5.4% in the 3rd quarter. Nu Skin Enterprises posted earnings of $0.51 per share in the same quarter last year, which would suggest a positive year over year growth rate of 31.4%. (NYSE:NUS) PTs and latest ratings. Nu Skin Enterprises has an average rating of "Hold" and an average target price of $71.29. Alpha Windward Ltd holds 339 shares or 0.01% of its portfolio. Aqr Capital Mngmt Ltd reported 0.12% stake. In the last three months, insiders have sold 141,843 shares of company stock valued at $10,393,337. Commerzbank Aktiengesellschaft Fi reported 55,300 shares. Cadence Capital Management Ltd Liability Company holds 0.11% or 24,485 shares. Public Employees Retirement Association Of Colorado reported 12,010 shares or 0.01% of all its holdings. Anixter Intl Inc Com (NYSE:AXE) was raised too. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Capital Fund Management S.A. acquired a new position in shares of Nu Skin Enterprises during the third quarter valued at approximately $8,316,000. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. On Friday, April 13 the company was downgraded by Deutsche Bank. On Friday, February 16 the firm has "Buy" rating given by Deutsche Bank. The company was maintained on Thursday, February 15 by Stifel Nicolaus. The rating was downgraded by Sidoti on Wednesday, April 26 to "Neutral".

Since January 19, 2018, it had 0 insider purchases, and 8 insider sales for $116.91 million activity.

In related news, Chairman Steven Lund sold 22,891 shares of the stock in a transaction that occurred on Monday, January 22nd. On Friday, March 2 the insider DORNY D MATTHEW sold $218,070. (NYSE:NUS) or 3,000 shares. (NYSE:NUS). Another trade for 15,000 shs valued at $1.08 million was sold by Thomas Pisano R. After having $1.20 EPS previously, Nu Skin Enterprises, Inc.'s analysts see -44.17% EPS growth.

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. (NYSE:NUS) to report earnings on April, 26 after the close. During the same quarter in the previous year, the business posted $0.79 earnings per share. NUS's profit would be $36.37M giving it 26.50 P/E if the $0.67 EPS is correct.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Thursday, February 15th. At present, 0 analysts call it Sell, while 1 think it is Hold. The stock has a market capitalization of $2.89 billion, a price-to-earnings ratio of 21.55 and a beta of 1.66. The Company's integrated suite of multi-disciplinary computer aided engineering software optimizes design performance across various disciplines, including structures, motion, fluids, thermal management, electromagnetics, system modeling and embedded systems, as well as provides data analytics and true-to-life visualization and rendering.

Other reports by Click Lancashire

Discuss This Article